CME Group share price today

CME Group Inc.'s share price was $305.92 at the close on 6 November 2026. It has been stalling near its high for 5 weeks. That is 8.9% above its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today CME Group Inc. is in stage 3. The phase helps read everything below.

In the last 52 weeks it traded between $221 and $320, and at that close it sat 86% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 8 weeks in a row.

Over the last 10 years the share price moved +209% while the S&P 500 moved +246%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

CME Group Inc. paid $5.15 per share over the last four reported quarters. The most recent declaration was $1.30 for Sep 2026. At today's price of $305.92 that is a yield of 1.68%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

CME Group is on one of our US lists: S&P 500 companies.

CME Group Inc. earned $1.0 B of net profit in the Sep 2026 quarter, +15.6% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY25 profit was $4.0 B. Over 4 years profit has grown 11.3% a year on average. That is 59.8% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $897 M.

For the full year, FY25 profit was $4.0 B (+15.5% on the year before).

Why profit moved: revenue changed +13.0% on a year earlier and the margin moved +1.4 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +19.0% and revenue +9.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

CME Group Inc. reported $1.7 B of income in the Sep 2026 quarter, +13.0% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown 8.5% a year on average. The last full year, FY25, came in at $6.5 B.

For a bank, revenue is everything it earns: interest on its loans plus fees from its businesses.

The last four reported quarters add to $7.0 B.

FY25 revenue was $6.5 B, +6.3% on the year before.

Recent pace: the last four quarters grew +9.1% on average, against 8.5% a year over the longer run, so this year is growing at about the same pace as its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +8.9%, against +7.4% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +18.4%, against +13.4% a year (accelerating).

CME Group Inc.'s net margin was 59.8% in the Sep 2026 quarter, 1.4 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 52.9% and 61.8%. The latest quarter is within that range.

Net margin is what the bank keeps from every $100 of revenue after every cost, provision for bad loans and tax. With big fee businesses in the mix, it is the clearest margin we can read for this bank.

Across 5 years it has been between 52.9% and 61.8%, and FY25's 61.8% is the highest of them.

Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

CME Group Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report.

Gross NPA is the share of the loan book where repayments have stopped. Net NPA is what is left after the money the lender has already set aside for those loans. Falling is good; rising is a warning.

Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up.

CME Group Inc.'s revenue was $6.5 B in FY25, +6.3% on the year before, so the loan book is growing. The latest quarter was +13.0% on a year earlier. The net margin on that income is 59.8%, +1.4 percentage points on a year ago.

We read the loan book through revenue: when the book and the businesses grow, revenue grows with them. It is only a rough guide, because interest-rate changes and fee swings can move it a few points in any year.

Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year.

In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch.

CME Group Inc.'s P/BV is 4.1×, about the highest it has ever been. Its usual P/BV (the middle reading) is 2.9×, over 5.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

For a bank or lender we compare the price with book value, the net worth on its balance sheet. P/BV is how many dollars the market pays for each $1 of that net worth. Below 1× means the market values it at less than its net worth.

Why the multiple is where it is: over the past year book value grew while the price moved +10.6%. The price ran ahead of book value, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved +6.7% a year; about −0.4% a year came from book-value growth and about +7.1 percentage points from the multiple (the market paying more). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the book value trend underneath matters more than the multiple.

CME Group Inc.'s business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROE is steady at 16.6%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: steady growth with healthy returns is how a business compounds over time.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

CME Group Inc. earned a return on equity of 14% in FY25. Its lowest yearly reading on file was 10% in FY21. On its assets, every $100 earned about $1.52, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together.

Two numbers rate a bank: ROE, what it earns on shareholders’ money, and ROA, what it earns on all its assets. An ROE above about 13 to 15% is healthy; below that, net worth grows slowly.

That is above the level a bank needs to grow its net worth steadily.